Related Experiment Videos
Suppressor substance produced by the K562 cell line in vitro
Journal of Surgical Oncology
|May 1, 1983
Summary
Human cultured cell lines, K562, NALM-1, and Daudi, were tested for suppressive activity toward normal lymphocytes. K562 cell line elaborated material that effectively suppressed T-cell responses, unlike Daudi and NALM-1.
Area of Science:
- Immunology
- Cell Biology
- Oncology
Background:
- Lymphoreticular malignancies can lead to immunosuppression.
- Understanding the mechanisms of cancer-induced immune suppression is crucial.
- Neoplastic cells may produce factors that modulate immune cell function.
Purpose of the Study:
- To investigate the immunosuppressive potential of supernatant fluids from human lymphoreticular malignancy cell lines.
- To determine if specific cell lines exhibit differential effects on normal lymphocyte functions.
- To explore the selective inhibition of lymphocyte responses by cancer-derived factors.
Main Methods:
- Culturing of human cell lines (K562, NALM-1, Daudi) derived from lymphoreticular malignancies.
- Collection and testing of supernatant fluids for suppressive activity on normal human lymphocytes in vitro.
- Assessment of lymphocyte responses to T-cell mitogens (phytohemagglutinin, concanavalin A) and mixed lymphocyte reaction.
Main Results:
- Supernatant from the K562 cell line demonstrated significant suppression of normal lymphocyte responses to T-cell mitogens and the mixed lymphocyte reaction.
- Supernatants from Daudi and NALM-1 cell lines showed little to no suppressive activity.
- Contrasting with previous findings, K562 did not inhibit B lymphocyte immunoglobulin synthesis.
Conclusions:
- The K562 cell line produces factors that selectively inhibit T-lymphocyte functions.
- Different neoplasms may elaborate distinct immunosuppressive molecules affecting specific immune cell subsets.
- These findings contribute to understanding cancer-associated immunosuppression and its selective nature.